Emsam (selegiline) will be the first PATCH for depression

April 2006

Emsam (selegiline) will be the first PATCH for depression.

It will be used as an alternative to oral MAO inhibitors... in patients who don't respond to other antidepressants.

Oral selegiline is selective for MAO-B at the low dose used for Parkinson's...but it's nonselective at higher doses needed for depression.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote